Burris, H. A. (2013). Overcoming acquired resistance to anticancer therapy: Focus on the PI3K/AKT/mTOR pathway. Cancer chemotherapy and pharmacology, 71(4), 829-842. https://doi.org/10.1007/s00280-012-2043-3
Chicago Style (17th ed.) CitationBurris, Howard A. "Overcoming Acquired Resistance to Anticancer Therapy: Focus on the PI3K/AKT/mTOR Pathway." Cancer Chemotherapy and Pharmacology 71, no. 4 (2013): 829-842. https://doi.org/10.1007/s00280-012-2043-3.
MLA (9th ed.) CitationBurris, Howard A. "Overcoming Acquired Resistance to Anticancer Therapy: Focus on the PI3K/AKT/mTOR Pathway." Cancer Chemotherapy and Pharmacology, vol. 71, no. 4, 2013, pp. 829-842, https://doi.org/10.1007/s00280-012-2043-3.
Warning: These citations may not always be 100% accurate.